Basel Medical (BMGL) Cash & Current Investments (2024 - 2025)
Basel Medical (BMGL) has disclosed Cash & Current Investments for 2 consecutive years, with $2.3 million as the latest value for Q2 2025.
- Quarterly Cash & Current Investments rose 62.19% to $2.3 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Jun 2025, up 62.19% year-over-year, with the annual reading at $2.3 million for FY2025, 62.19% up from the prior year.
- Cash & Current Investments hit $2.3 million in Q2 2025 for Basel Medical, up from $1.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $2.3 million in Q2 2025 to a low of $1.4 million in Q2 2024.